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Droplet digital PCR amplitude plot from stool DNA devoid of H. pylori spiked with three concentration of H. pylori 
genomic DNA. Each dot represents one droplet and dots above the line are considered to be positive for the H.pylori 
16s gene. 
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Approximately half of the world’s population is infected with the gastric bacterium Helicobacter pylori 
(H. pylori). While some cases of H. pylori infection can lead to gastric cancer, most infections remain 
either asymptomatic or can even be protective in esophageal cancer or asthma. A combination of 
environmental factors and genetics of both the host and pathogen contribute to disease outcome, so 
determining the strain characteristics of H. pylori present in infected individuals is an important goal 
of molecular epidemiology studies. However, current strategies for detecting and genotyping H. 
pylori require an endoscopy of the upper gastrointestinal tract, which prevents sampling from 
asymptomatic individuals. Therefore, there is an urgent need to develop effective non-invasive 
methods for genotyping H. pylori. A new Fred Hutch study led by Dr. Sarah Talarico, an associate in 
Dr. Nina Salama’s Laboratory (Public Health Sciences, Basic Sciences and Human Biology 
Divisions) and published in Helicobacter, accomplished just that by developing and validating a non-
invasive, stool-based method for genotyping H. pylori. 
A key feature of the study was a recent development in Polymerase Chain Reaction (PCR) 
technology, named droplet digital PCR (ddPCR), that uses a water-oil emulsion system to partition a 
20 microliter reaction into thousands of nanoliter-sized droplets. With this protocol, at most one DNA 
fragment is present in any droplet. The PCR reaction is carried out within each droplet and by 
determining the frequency of positive droplets, allows a quantitative readout. To develop the assay, 
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the researchers obtained matched stool and serum from 50 volunteers from a Costa Rican cohort as 
well as stool samples from 29 individuals that had been admitted to Harborview Medical Center in 
Seattle for various medical reasons. To test the performance of the assay, the authors introduced 
known quantities of H. pylori DNA into a stool DNA sample form an H. pylori negative volunteer. 
These experiments revealed a clear separation between droplets positive for the 16S ribosomal 
gene (a gene that is specific for each bacterial species) and droplets that lacked the 16S gene (see 
figure). The presence of the cagA gene in H. pylori and its allelic variants is associated with 
increased risk of developing gastric cancer. For example, the CagA protein is phosphorylated on an 
amino acid motif, EPIYA, which can classify a strain as either having an EPIYA-C or an EPIYA-D 
motif, with the latter being linked to increased gastric cancer risk. The cagA specific ddPCR correctly 
identified and determined the EPIYA type in 15 out of 16 strains tested (94%). Next, the researchers 
compared their ddPCR assay with other non-invasive assays such as the H. pylori serum antibody 
test. The ddPCR assay detected H. pylori in the stool of 27 out of 32 Costa Rican participants who 
were positive for serum antibodies and in 12 out of 12 that were positive in the stool antigen test 
from the Harborview participants. Intriguingly, there was considerable variation in the H. pylori load 
in both the Costa Rican and US samples, wherein samples that tested positive for CagA tended to 
have higher loads. Said Dr. Talarico "The quantitative nature of the droplet digital PCR method 
revealed variation in H. pylori load in the stool. Those infected with an H. pylori strain having the 
cagA virulence gene had a significantly higher H. pylori load, a correlation that has also been 
observed in the stomach. We are conducting additional studies to better understand the relationship 
between H. pylori load in the stomach and in the stool. We are excited to continue adapting this new 
stool-based method for future molecular epidemiologic studies to look at other H. pylori genotypes, 
including antibiotic resistance alleles, other virulence genes, and to determine strain ancestry. Since 
this non-invasive assay can be used even for the majority of H. pylori-infected individuals who are 
asymptomatic, this opens up many more study design possibilities". In summary, this study 
developed an assay to detect and genotype H. pylori that is both quantitative and non-invasive, and 
warrants further validation by using it with matched gastric biopsy samples from diverse populations. 
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